A study of the combination of oxaliplatin, capecitabine, and trastuzumab and chemo-radiotherapy in the adjuvant setting in operated patients with HER2+gastric or gastroesophageal junction cancer (TOXAG study).

Abali H., Yalcin S., Onal C., Dane F., Oksuzoglu B., Ozdemir N., ...More

Gastrointestinal Cancers Symposium, San-Francisco, Costa Rica, 18 - 20 January 2018, vol.36, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 36
  • Doi Number: 10.1200/jco.2018.36.4_suppl.26
  • City: San-Francisco
  • Country: Costa Rica
  • Hacettepe University Affiliated: Yes